Vincent de Caprio
Directeur/Bestuurslid bij New Jersey Institute of Technology
Profiel
Vincent de Caprio was President and Chief Executive Officer of Vyteris Holdings, Inc. He joined Vyteris Holdings, Inc. in 2000.
He is a Fellow of the American Institute of Medical and Biological Engineering.
He is a Trustee of New Jersey Institute of Technology.
He received a BSEE degree from the Newark College of Engineering in 1972, an MS degree in 1975 from Polytechnic University and a PhD in 1977 from Polytechnic University.
Actieve functies van Vincent de Caprio
| Bedrijven | Functie | Begin |
|---|---|---|
| New Jersey Institute of Technology | Directeur/Bestuurslid | - |
Eerdere bekende functies van Vincent de Caprio
| Bedrijven | Functie | Einde |
|---|---|---|
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | President | 31-12-2005 |
| Treasure Mountain Holdings, Inc. | President | 17-05-2005 |
Opleiding van Vincent de Caprio
| New Jersey Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Treasure Mountain Holdings, Inc. | Producer Manufacturing |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
| Polytechnic University | Consumer Services |
